Related Experiment Video
Updated: Jul 27, 2026
11:49
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
16.3K
CNS Post-Transplant Lymphoproliferative Disorder in a Heart Recipient: A Case Report.
A Amin1, M Chenaghlou2, E Zare3
1Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
International Journal of Organ Transplantation Medicine
|January 6, 2022
Summary
Solid organ transplant recipients face higher cancer risks. Primary CNS lymphoma, a rare post-transplant malignancy, requires early detection for effective management, as highlighted in a heart recipient case study.
Area of Science:
- Oncology
- Neurology
- Transplantation Medicine
Background:
- Solid organ recipients have a significantly higher risk of developing malignancies compared to the general population.
- Post-transplant lymphoproliferative disorders (PTLD) represent the second most common malignancy in transplant patients.
- Primary central nervous system (CNS) lymphoma is an uncommon manifestation of PTLD.
Observation:
- Neurologic complications are frequent in the post-transplant period.
- Specific clinical features may aid in the early diagnosis of primary CNS lymphoma.
- A young female heart transplant recipient presented with focal neurologic symptoms 14 months post-transplantation.
Findings:
- The case highlights the diagnostic challenges posed by the rarity of primary CNS lymphoma.
- Identifying characteristic neurologic symptoms is crucial for timely diagnosis.
- Early detection is paramount for optimizing patient management and outcomes.
Implications:
- This case underscores the importance of considering rare neurological conditions like primary CNS lymphoma in solid organ transplant recipients.
- Awareness of specific clinical indicators can facilitate earlier diagnosis and intervention.
- Improved diagnostic strategies for CNS lymphoma in transplant patients are needed to enhance survival rates.
